IbrutinibiMpuritySYGIM
97%
- Product Code: 201077
CAS:
1642630-12-3
| Molecular Weight: | 386.45 g./mol | Molecular Formula: | C₂₂H₂₂N₆O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used in the treatment of various B-cell malignancies including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia. It functions as a potent inhibitor of Bruton's tyrosine kinase (BTK), which plays a crucial role in B-cell receptor signaling, leading to reduced proliferation and survival of malignant B cells. Also investigated for use in autoimmune disorders due to its modulation of immune cell activity. Administered orally, it offers a targeted therapy approach with improved patient outcomes compared to traditional chemotherapy.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50mg | 10-20 days | ฿9,500.00 |
+
-
|
IbrutinibiMpuritySYGIM
Used in the treatment of various B-cell malignancies including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia. It functions as a potent inhibitor of Bruton's tyrosine kinase (BTK), which plays a crucial role in B-cell receptor signaling, leading to reduced proliferation and survival of malignant B cells. Also investigated for use in autoimmune disorders due to its modulation of immune cell activity. Administered orally, it offers a targeted therapy approach with improved patient outcomes compared to traditional chemotherapy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :